Jump to content
This site uses cookies. Continued use is acceptance of our Terms of Use and Privacy Policy. More Info... ×
  • Welcome to Celiac.com!

    You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.




  • Celiac.com Sponsor (A1):



    Celiac.com Sponsor (A1-M):


  • Get Celiac.com Updates:
    Support Our Content
    eNewsletter
    Donate
  • Dr. Ron Hoggan, Ed.D.
    Dr. Ron Hoggan, Ed.D.

    They've Done It Again!

    Reviewed and edited by a celiac disease expert.

    Journal of Gluten Sensitivity Autumn 2009 Issue. NOTE: This article is from a back issue of our popular subscription-only paper newsletter. Some content may be outdated.

    They've Done It Again! - Before. Image: CC BY 2.0--Me in ME
    Caption: Before. Image: CC BY 2.0--Me in ME

    Celiac.com 01/23/2020 - Researchers at the University of Maryland, under Alessio Fasano, have, once more, expanded the boundaries of human knowledge.  The implications of their most recent discovery may soon unlock the mysteries of several autoimmune conditions including celiac disease, inflammatory bowel disease, type 1 diabetes, multiple sclerosis, and some types of cancers.  Their discovery and subsequent report of zonulin, in 2000, was an enormous step forward.  It provided insight into one, perhaps the only, common mechanism that causes leaky gut.  Until then, many theories about leaky gut were proffered but none could be substantiated.  We only knew that some autoimmune diseases, bowel diseases, and food allergies (or delayed sensitivities as some call them) seemed to trigger a leaky gut.  Many of those with food allergies seemed to get some relief from eliminating foods to which their immune systems reacted, but we really did not understand the process by which these allergenic substances and various diseases induced a leaky gut.  

    However, with the discovery and subsequent characterization of zonulin, it quickly became clear that a leaky gut was an important precursor to the development of at least some forms of autoimmunity. Although many medical practitioners continue to express skepticism about the importance of a leaky gut, emerging research findings should soon quell their concerns.  

    Celiac.com Sponsor (A12):
    Subsequent pharmacological research by Alba Therapeutics suggests that we may soon be able to abolish the permeable intestine that underlies so many autoimmune and other debilitating conditions.  Currently in clinical trials, Alba Therapeutics is finding that Larazotide Acetate (formerly AT 1001) is abolishing the inflammatory sequelae when individuals with celiac disease consume gluten.  

    Healthy digestion involves absorption of tiny, digested particles into the epithelial cells that line the intestine.  These particles are then passed out the other side of the cell and into the bloodstream. These cells line the gut and maintain tight junctions to provide a protective barrier, except when zonulin attaches at cellular receptors. That is when the cells move further apart, allowing larger, undigested molecules to bypass the epithelial cells.  

    Larazotide is designed to capture excess zonulin, which is over-produced by genetically susceptible individuals in response to ingested gluten.  This drug is designed to capture the excess zonulin proteins and waste them in fecal matter, rather than allowing them to attach at receptors on epithelial cells.  It is by this means that Larazodide is designed to prevent the development of a leaky gut, regardless of the cause of excessive zonulin production.  

    Readers familiar with my work will not be surprised to learn that I’m not planning on eating gluten anytime soon.  But I’d sure like to be able to take a pill containing an otherwise harmless substance, when dining out, whether at restaurants or at friends’ homes.  I’d also like a tool that will help me to identify any other foods against which I may be mounting an inflammatory immune response.  

    I imagine getting up in the morning and eating a couple of pancakes made from bean flours that I’m currently not able to tolerate.  If I take some Larazotide first, and I get through the morning without my typical reactions–bloated stomach and heartburn–then I’ll know both what the culprit is and what I can do if I really want to have a couple of bean flour pancakes one morning. 

    Similarly (and much more importantly) it will provide people with a tool for helping them to determine whether they are experiencing symptoms of food allergies or if their discomfort is caused by something else.  For instance, if someone is unsure whether their foggy thinking really is the result of eating gluten, they can try Larazotide for a couple of meals.  If their foggy brain clears up, but returns when they stop Larazotide and eat a meal containing gluten, then they will know that food (probably gluten) is likely the culprit.  They may wish to pursue further self-testing or laboratory testing to identify specific problematic foods.

    This drug may also provide a tool for investigating children with attention deficit disorders (ADHD). If food sensitivities are the underlying culprit, these children should behave and pay attention fairly normally after a period of taking Larazotide before they consume any foods.  We currently have no idea just how long such an intervention might take, but I’m hoping that researchers will soon answer such questions.  

    I recently attended a conference on Crohn’s and colitis.  When talking about treatments, the primary issues under discussion were the impact of various drugs on individuals present.  The patients present shared a wealth of pharmaceutical knowledge.  There was also considerable discussion of research aimed at a cure.  In fact, the hosting organization seems quite fixated on finding a cure in the very near future. What a boon it would be, for everyone concerned, if Larazotide turns out to be that cure!

    But we knew all of this before.  In fact, I’ve detailed most of this information in previous issues.  What is new, and intensely exciting, is that the research group at U.  Maryland has now determined that zonulin not only functions to increase intestinal permeability and inflammation, it is also a precursor to haptoglobin 2, a marker of inflammation  that is exclusive to human beings.  No other primates produce this protein, and only 80% of humans produce it.  Considerable research has connected sub-groups of this marker to a variety of cardiovascular diseases, a range of autoimmune conditions, and many cancers.  

    Thus, the production of zonulin, which will ultimately mature into haptoglobin 2, is a feature of many more ailments than was previously imagined.  Since Larazotide is designed to capture and waste zonulin in fecal matter, we will soon be able to see what impact this drug can have on a variety of autoimmune diseases–and it promises to offer a tremendous benefit by halting the leakage of undigested proteins into the bloodstream that may be triggering autoimmune reactions by a process known as molecular mimicry.  

    But that isn’t all Larazotide might offer.  It could also offer insight into what has been characterized as the plague of the Twentieth Century, cancer.  These inflammatory markers, haptaglobin 2, are elevated in association with many cancers.  If the inflammation proves to be a significant factor in the survival of tumors, we will be able to block its production and deny this substance to the cancerous tissues.  If, on the other hand, these inflammatory markers help the immune system to destroy tumors, we know how to trigger its production (in 80% of humans) and autoimmunity can be deterred by intravenous feeding during treatment.  Either way, there is genuine cause for hope.  

    My money is on the former possibility.  I suspect removal of excess zonulin will reduce malignancies, but that is because diet can play an enormous role in cancer.  There is already considerable anecdotal evidence suggesting a ketogenic diet is a viable therapy for insulin sensitive cancers.  Time magazine ran a feature article titled “Can a High Fat Diet Beat Cancer?” in their September 17, 2007 issue.  (The greatest difficulty these researchers are encountering with these trials is dietary compliance. Another serious problem is that their ethical approval required that all conventional treatments be exhausted before beginning the dietary trial.  Thus, many of their research subjects are very sick before they begin the diet.  For these reasons, one of the universities has stopped running these trials despite some promising preliminary results.) Whichever way it goes, Larazotide may well lead to some dramatic advances in cancer research in the very near future.  

    Larazotide may also help some type 1 diabetics turn back the clock.  Those who undergo islet cell transplants can usually only expect a year or two of reduced insulin requirements before they return to their former status.  Larazotide may be able to halt the autoimmune destruction of the islet cells which produce insulin, allowing individuals who undergo transplants to experience relatively normal lives, without worrying about balancing the size of their insulin injections with their carbohydrate intake.  They may well be able to forego injections entirely for the rest of their lives.  

    Individuals with various autoimmune diseases may be able to halt the progression of their illness and return to more normal lives.  Those with multiple sclerosis, Crohn’s disease, some forms of arthritis, lupus, and a host of other ailments may be stopped in their tracks.  There may even be hope that people like me, with chronic lung disease, will be able to begin rebuilding healthy lung tissues.  Reduced haptoglobin 2 may result in reductions in inflammatory reactions to airborne allergens.  This, in turn, may permit us to breathe well enough that we can exercise and build healthy lung tissues without scar tissues.  I’m not suggesting that we will be able to return to our 25 year-old activities, but I believe we may be able to live more normal, more productive lives for whatever time we have left.  

    Finally, Larazotide may even bring about reductions in the excess mortality found in the celiac disease and gluten sensitive community.  We have a lot to be grateful for. The research group directed by Alessio Fasano is making enormous contributions to broadening medical understanding of celiac disease, expanding medical knowledge of autoimmunity and cancer, and increasing celiac awareness (see:  Scientific American, August 2008, “Surprises from Celiac Disease” by Alessio Fasano). As I said at the beginning, “They’ve done it again!”


    User Feedback

    Recommended Comments

    Karoxy

    How can we test for the inflammatory markers, haptaglobin 2.  I've gotten several endoscopies and inflammation always comes up but they cannot tell me what is causing this inflammation.  

    Link to comment
    Share on other sites


    Create an account or sign in to comment

    You need to be a member in order to leave a comment

    Create an account

    Sign up for a new account in our community. It's easy!

    Register a new account

    Sign in

    Already have an account? Sign in here.

    Sign In Now

  • Get Celiac.com Updates:
    Support Celiac.com:
    Donate
  • About Me

    Dr. Ron Hoggan, Ed.D.

    As co-author of "Dangerous Grains" and "Cereal Killers", the study of the impact of gluten continues to be a driving passion in my life. I am fascinated by the way that gluten induces illness and impedes learning while it alters mood, behavior, and a host of other facets of our existence. Sure, the impact of gluten on health is an important issue, but that is only the most obvious area of impact. Mood disturbances, learning disabilities, and the loss of quality of life due to psychiatric and neurological illness are even more tragic than the plethora of physical ailments that are caused or worsened by gluten. The further I go down this rabbit hole, the more I realize that grains are a good food for ruminants - not people. I am a retired school teacher. Over the last decade, I have done some college and university level teaching, but the bulk of my teaching career was spent working with high school students.


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-M):




  • Related Articles

    Scott Adams
    Celiac.com 05/14/2000 - Scientists from the University of Maryland have discovered that people with the autoimmune disorder celiac disease have higher levels of the protein zonulin in their bodies. This discovery may ultimately lead to more insight into the causes of other autoimmune diseases, including diabetes, multiple sclerosis and rheumatoid arthritis. In people with celiac disease who eat gluten, which is found in wheat, rye and barley, an autoimmune reaction is set off that creates antibodies that end up attacking their intestines. This causes symptoms like diarrhea and abdominal pain, and may lead to long-term damage and a large host of other problems. Researchers at the University of Maryland have finally found the cause of this curious reaction: a protein in the body...


    Scott Adams
    Celiac.com 02/25/2005 - Today a team of scientists at Alba Therapeutics Corporation and the University of Maryland School of Medicine report a direct link between zonulin-mediated increased intestinal permeability and Type 1 Diabetes (T1D) in the BB/wor Rat Model of Diabetes. Even more remarkable, the investigators were able to successfully prevent the onset of the autoimmune destruction of pancreatic beta cells and the onset of T1D in these animals by using the specific zonulin blocker AT-1001. Daily, oral administration of the drug beginning before the onset of auto-immunity in the diabetic prone rats cut the incidence of the disease by 2/3, and completely blocked the development of autoimmune antibodies in the treatment responders.
    Published in the latest issue of the Proceedings...


    Scott Adams
    Celiac.com 11/08/2005 - Today a team of scientists at Alba Therapeutics Corporation (Alba) and the University of Maryland School of Medicine reported a direct link between gluten-induced intestinal permeability and zonulin in tissues from patients with celiac disease. The investigators were able to successfully prevent gluten-induced intestinal tissue leak with the administration of the zonulin antagonist FZI/0 (AT-1001). AT-1001 is an orally administered peptide currently under development for the treatment of celiac disease. Published in the November issue of the Scandinavian Journal of Gastroenterology, these results describe the role that leaky gut plays in celiac disease and the role that zonulin plays in establishing the leak. These results are another milestone towards understanding...


    Jefferson Adams
    Elevated Serum Zonulin in IBS Correlates with Stool Frequency in IBS-D
    Celiac.com 07/30/2019 - Studies have shown increased intestinal permeability in irritable bowel syndrome. Validating serum biomarkers for altered intestinal permeability in irritable bowel syndrome will facilitate research and pathophysiology-based therapy.
    A team of researchers recently set out to measure serum zonulin and intestinal fatty acid binding protein levels in diarrhea-predominant irritable bowel syndrome and constipation-predominant irritable bowel syndrome, and to compare the results with healthy control and celiac disease subjects.
    The research team included Prashant Singh, Jocelyn Silvester, Xinhua Chen, Hua Xu, Veer Sawhney, Vikram Rangan, Johanna Iturrino, Judy Nee, Donald R. Duerksen, and Anthony Lembo. They are variously affiliated with the Division of ...


  • Recent Activity

    1. - cristiana replied to Kathleen JJ's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      1

      Options - 7 year old boy - Helicobacter pylori and serology

    2. - Kathleen JJ posted a topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      1

      Options - 7 year old boy - Helicobacter pylori and serology

    3. - Wheatwacked replied to CeliacChica's topic in Related Issues & Disorders
      29

      Muscle Twitching

    4. - trents replied to jjiillee's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      5

      Daughter waiting for appointment

    5. - jjiillee replied to jjiillee's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      5

      Daughter waiting for appointment


  • Celiac.com Sponsor (A19):



  • Member Statistics

    • Total Members
      126,052
    • Most Online (within 30 mins)
      7,748

    Kathleen JJ
    Newest Member
    Kathleen JJ
    Joined

  • Celiac.com Sponsor (A20):


  • Forum Statistics

    • Total Topics
      120.9k
    • Total Posts
      69.1k

  • Celiac.com Sponsor (A22):





  • Celiac.com Sponsor (A21):



  • Popular Now

    • Captain173
      10
    • jjiillee
      5
    • Kristina12
      7
    • StaciField
    • ShRa
      9
  • Popular Articles

    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
  • Upcoming Events

×
×
  • Create New...